NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy
NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy
复制标题
DOI:
10.1111/j.1528-1157.1999.tb01985.x
复制
发表时间:
1999-01-01
期刊:
影响因子:
5.6
通讯作者:
Långström, B
中科院分区:
文献类型:
--
作者:
Kumlien, E;Hartvig, P;Långström, B
Purpose: To determine whether neurochemical activation of the N-methyl-D-aspartate (NMDA) receptor-gated ion channel shows quantitative changes, measured as binding of C-11-labeled (S)-[N-methyl]ketamine, in patients with medial temporal lobe epilepsy (MTLE).Methods: Eight patients with MTLE who were evaluated regarding epilepsy surgery underwent positron emission tomography (PET) with (S)-[N-methyl-C-11]ketamine. The presurgical investigations included magnetic resonance imaging (MRI), PET with F-18-fluoro-deoxyglucose ((18)FDG), and seizure monitoring by using video-EEG. The uptake of (S)-[N-methyl-C-11]ketamine in the temporal lobe of ictal onset was compared with the contralateral side and correlated to changes in regional glucose metabolism measured by PET with (18)FDG.Results: (S)-[N-methyl-C-11]ketamine rapidly reached the brain, and high radioactivities were measured in the striatum, thalamic nuclei, and cortical regions. Overall the brain uptake and regional binding potentials of (S)-[N-methyl-C-11]ketamine were similar to measurements observed previously in healthy controls. However, 20 min after administration, when blood flow influence was negligible, a side-to-side comparison revealed a 9-34% reduction of tracer radioactivity in the temporal lobes of ictal onset. At earlier times, the differences in binding potentials were less pronounced, 9-21%. The magnitude and distribution of the reduction were similar to the metabolic pattern seen on PET scans with (18)FDG.Conclusions: Radioactivity uptake of intravenously administered (S)-[N-methyl-C-11]ketamine was reduced in temporal lobes of ii tal in patients with TLE. This may reflect reduced NMDA-receptor density, reduced perfusion, focal atrophy, or other factors.